Evidence map›Paper›PMID 32156805›Full record

ArticlemBio2020

Joshua Mayoral, Peter Shamamian, Louis M Weiss

Open access · goldAbstract read
In one paragraph

Article in mBio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Getting on your last nerve: IFNs and resistance to infection.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  2. Article
  3. Article
  4. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Bicyclic Pyrrolidine Inhibitors ofACS infectious diseases · 2024
    Article
  7. Article
  8. Bicyclic pyrrolidine inhibitors ofbioRxiv : the preprint server for biology · 2024
    Article
  9. A Combination of Four Nuclear Targeted Effectors ProtectsbioRxiv : the preprint server for biology · 2023
    Article
  10. Use ofFrontiers in cellular and infection microbiology · 2023
    Review
  11. Mining the Proteome ofAnimals : an open access journal from MDPI · 2022
    Review
  12. Single Cell Transcriptomes ofFrontiers in cellular and infection microbiology · 2022
    Article
  13. Review
  14. Article
  15. Secreted Effectors Modulating Immune Responses toLife (Basel, Switzerland) · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joshua MayoralDepartment of Pathology, Albert Einstein College of Medicine, New York, New York, USA.
Peter ShamamianDepartment of Pathology, Albert Einstein College of Medicine, New York, New York, USA.
Louis M WeissDepartment of Pathology, Albert Einstein College of Medicine, New York, New York, USA louis.weiss@einstein.yu.edu.ORCID 0000-0002-0357-7396
Albert Einstein College of Medicine · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
Composition and formation of the cyst wallR01AI134753 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI WEISS, LOUIS M. · 2018 to 2022
$2.1M
Advanced Confocal Microscope in a multi-user facilityS10OD023591 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BAKER, NICHOLAS E · 2017 to 2017
$590k
Toxoplasma gondii GlycosylationR21AI123495 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI WEISS, LOUIS M. · 2017 to 2018
$489k
120kV Transmission Electron Microscope for a Multi-user Microscopy FacilityS10OD016214 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CONDEELIS, JOHN S · 2014 to 2014
$459k
High-speed/resolution whole slide scanner supported by two core facilitiesS10OD019961 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CONDEELIS, JOHN S · 2015 to 2015
$326k
Secreted effectors of Toxoplasma gondii bradyzoitesF31AI136401 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MAYORAL, JOSHUA ALEXANDER · 2018 to 2019
$83k
NCI NIH HHS P30 CA013330NIAID NIH HHS F31 AI136401NIAID NIH HHS R01 AI134753NIAID NIH HHS R21 AI123495NIH HHS S10 OD016214NIH HHS S10 OD019961
6 · The paper itself

Abstract

The ubiquitous parasite

Indexed as

Host-Parasite InteractionsLife Cycle StagesProtein TransportAnimalsCell NucleusCells, CulturedFluorescent Antibody TechniqueMiceMice, Inbred C57BLProteomicsProtozoan ProteinsSignal TransductionToxoplasmaProtozoan Proteinsbradyzoiteeffector functionsGRA proteinsinterferon gammaTgISTToxoplasma gondii

Identifiers

PMID32156805
PMCPMC7064745
OpenAlexW3011342321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.